Fundraising Fox
Atsenatx
Austin, US · 51 employees on LinkedIn · 4 known investors
Find your way into Atsenatx
Sign up to see every warm intro you have to Atsenatx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atsenatx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss. The company focuses on genetic medicines for conditions with limited approved therapies, utilizing proprietary AAV technology platforms.
Investors · 4
Lightstone Ventureslisted by Lightstone VenturesPortola Valley
How we know: the VCSheet dataset · Not right? Tell us
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
How we know: the VCSheet dataset · Not right? Tell us
Sofinnova VenturesreportedMenlo Park · $100K – $15M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Atsenatx do?
- Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss. The company focuses on genetic medicines for conditions with limited approved therapies, utilizing proprietary AAV technology platforms.
- Who are Atsenatx's investors?
- Atsenatx's investors include Lightstone Ventures, Wellington Management, Hatteras Venture Partners, Sofinnova Ventures.
- Where is Atsenatx headquartered?
- Atsenatx is headquartered in Austin, US.